LISATA THERAPEUTICS, INC. Liabilities Assumed
LISATA THERAPEUTICS, INC. (LSTA) reported Liabilities Assumed of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2024-02-29
- LISATA THERAPEUTICS, INC. liabilities assumed for the quarter ending 2023-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. liabilities assumed for the quarter ending 2022-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. liabilities assumed for the quarter ending 2021-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. liabilities assumed for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- LISATA THERAPEUTICS, INC. liabilities assumed for fiscal 2022 was $2.14M.
- LISATA THERAPEUTICS, INC. liabilities assumed for fiscal 2021 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.14M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $2.14M 10-Q · filed 2023-11-02 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |